Operating Segments

9 Months Ended

Sep. 30, 2020

Segment Reporting [Abstract]

Operating Segments

Note 9. Operating Segments

The Company maintains two active operating segments: Specialized BioTherapeutics and Public Health Solutions. Each segment includes an element of overhead costs specifically associated with its operations, with its corporate shared services group responsible for support functions generic to both operating segments.

	Three Months Ended
	September 30,
		2020			2019
Revenues
Public Health Solutions	$	544,466		$	991,087
Specialized BioTherapeutics		64,345			263,817
Total	$	608,811		$	1,254,904
(Loss) Income from Operations
Public Health Solutions	$	(6,369	)	$	72,491
Specialized BioTherapeutics		(643,793	)		(1,926,883	)
Corporate		(1,162,615	)		(912,207	)
Total	$	(1,812,777	)	$	(2,766,599	)
Amortization and Depreciation Expense
Public Health Solutions	$	6,651		$	4,312
Specialized BioTherapeutics		3,201			4,141
Corporate		7,335			6,448
Total	$	17,187		$	14,901
Other Income, Net
Specialized BioTherapeutics	$	22,131		$	8,809
Corporate		486			37,007
Total	$	22,617		$	45,816
Share-Based Compensation
Public Health Solutions	$	8,377		$	8,072
Specialized BioTherapeutics		18,962			18,609
Corporate		39,233			54,846
Total	$	66,572		$	81,527

	Nine Months Ended
	September 30,
		2020			2019
Revenues
Public Health Solutions	$	1,921,284		$	2,767,304
Specialized BioTherapeutics		117,369			1,177,351
Total	$	2,038,653		$	3,944,655
(Loss) Income from Operations
Public Health Solutions	$	(215,608	)	$	267,601
Specialized BioTherapeutics		(9,810,296	)		(4,725,774	)
Corporate		(3,074,534	)		(2,773,380	)
Total	$	(13,100,438	)	$	(7,231,553	)
Amortization and Depreciation Expense
Public Health Solutions	$	21,272		$	13,030
Specialized BioTherapeutics		9,438			12,986
Corporate		21,925			11,876
Total	$	52,635		$	37,892
Other Income, Net
Specialized BioTherapeutics	$	90,838		$	11,479
Corporate		24,450			125,467
Total	$	115,288		$	136,946
Share-Based Compensation
Public Health Solutions	$	26,219		$	21,340
Specialized BioTherapeutics		63,213			58,611
Corporate		121,834			154,041
Total	$	211,266		$	233,992

		As of		As of
		September 30,		December 31,
		2020		2019
Identifiable Assets
Public Health Solutions	$	357,798	$	1,018,673
Specialized BioTherapeutics		54,944		41,705
Corporate		12,837,336		6,714,982
Total	$	13,250,078	$	7,775,360